Cardiovascular consequences of obstructive sleep apnea.

Sleep apnea is associated with several cardiovascular disease conditions. A causal relationship between sleep apnea and each of these diseases is likely, but remains to be proven. The clearest evidence implicating OSA in the development of new cardiovascular disease involves data that show an increased prevalence of new hypertension in patients with OSA followed over 4 years [3]. Circumstantial evidence and data from small study samples suggest that OSA, in the setting of existing cardiovascular disease, may exacerbate symptoms and accelerate disease progression. The diagnosis of OSA always should be considered in patients with refractory heart failure, resistant hypertension, nocturnal cardiac ischemia, and nocturnal arrhythmias, especially in individuals with risk factors for sleep apnea (e.g., central obesity, age, and male gender). Treating sleep apnea may help to achieve better clinical control in these diseases and may improve long-term cardiovascular prognosis.

[1]  B. Grant,et al.  Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea. , 2002, Chest.

[2]  H. Minemura,et al.  Daytime hypertension and the effects of short-term nasal continuous positive airway pressure treatment in obstructive sleep apnea syndrome. , 1995, Internal medicine.

[3]  J. Manson,et al.  Snoring and risk of cardiovascular disease in women. , 2000, Journal of the American College of Cardiology.

[4]  J Sellgren,et al.  Augmented resting sympathetic activity in awake patients with obstructive sleep apnea. , 1993, Chest.

[5]  S. Ancoli-Israel,et al.  The effect of sleep apnea on plasma and urinary catecholamines. , 1995, Sleep.

[6]  P. Lavie,et al.  Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. , 2002, American journal of respiratory and critical care medicine.

[7]  T. Gislason,et al.  Sleep‐disordered breathing and glucose metabolism in hypertensive men: a population‐based study , 2001, Journal of internal medicine.

[8]  B. Ehrenberg,et al.  Platelet activation, epinephrine, and blood pressure in obstructive sleep apnea syndrome , 1998, Neurology.

[9]  D. Hillman,et al.  Association of sleep apnoea with myocardial infarction in men , 1990, The Lancet.

[10]  Berndt Lüderitz,et al.  Obstructive Sleep Apnea as a Risk Marker in Coronary Artery Disease , 2000, Cardiology.

[11]  K. Franklin,et al.  Sleep apnoea and nocturnal angina , 1995, The Lancet.

[12]  J. Peter,et al.  Outcome of patients with sleep apnea-associated severe bradyarrhythmias after continuous positive airway pressure therapy. , 2000, The American journal of cardiology.

[13]  R. Elsner,et al.  ROLE OF CAROTID-BODY CHEMORECEPTORS AND THEIR REFLEX INTERACTIONS IN BRADYCARDIA AND CARDIAC ARREST , 1979, The Lancet.

[14]  S. Javaheri,et al.  Association of Low Paco 2 with Central Sleep Apnea and Ventricular Arrhythmias in Ambulatory Patients with Stable Heart Failure , 1998, Annals of Internal Medicine.

[15]  W K Lam,et al.  Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. , 2000, American journal of respiratory and critical care medicine.

[16]  D. Sajkov,et al.  Pulmonary hypertension and hypoxemia in obstructive sleep apnea syndrome. , 1994, American journal of respiratory and critical care medicine.

[17]  W. Seeger,et al.  Decreased plasma levels of nitric oxide derivatives in obstructive sleep apnoea: response to CPAP therapy , 2000, Thorax.

[18]  D. Good,et al.  Sleep-disordered breathing and poor functional outcome after stroke. , 1996, Stroke.

[19]  F. Yasuma,et al.  Cardiac hypertrophy in obstructive sleep apnea syndrome. , 1995, Chest.

[20]  R. Henthorn,et al.  Asymptomatic Brady arrhythmias as a Marker for Sleep Apnea: Appropriate Recognition and Treatment May Reduce the Need for Pacemaker Therapy , 1996, Pacing and clinical electrophysiology : PACE.

[21]  G. Bernardi,et al.  Cerebral hemodynamic changes in sleep apnea syndrome and effect of continuous positive airway pressure treatment , 1998, Neurology.

[22]  K. Nakao,et al.  Plasma leptin levels and cardiac sympathetic function in patients with obstructive sleep apnoea-hypopnoea syndrome , 2002, Thorax.

[23]  M. Mishima,et al.  Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. , 2000, The American journal of medicine.

[24]  F. Abboud,et al.  Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. , 1989, Journal of applied physiology.

[25]  D. Léger,et al.  Cardiorespiratory consequences of sleep apnoea syndrome in patients with massive obesity , 1998, European Respiratory Journal.

[26]  T. Young,et al.  Prospective study of the association between sleep-disordered breathing and hypertension. , 2000, The New England journal of medicine.

[27]  J. Nahmias,et al.  Right ventricular dysfunction in obstructive sleep apnoea: reversal with nasal continuous positive airway pressure. , 1996, The European respiratory journal.

[28]  J. Peter,et al.  Sleep-related myocardial ischemia and sleep structure in patients with obstructive sleep apnea and coronary heart disease. , 1997, Chest.

[29]  D. Bates,et al.  Snoring increases the risk of stroke and adversely affects prognosis. , 1992, The Quarterly journal of medicine.

[30]  J. Montserrat,et al.  Time course of sleep-related breathing disorders in first-ever stroke or transient ischemic attack. , 2000, American journal of respiratory and critical care medicine.

[31]  A. Thilmann,et al.  Fibrinogen levels and obstructive sleep apnea in ischemic stroke. , 2000, American journal of respiratory and critical care medicine.

[32]  Bonnie K. Lind,et al.  Association of Sleep-Disordered Breathing, Sleep Apnea, and Hypertension in a Large Community-Based Study , 2000 .

[33]  W. Pankow,et al.  Sleep-disordered breathing and hypertension. , 2000, The New England journal of medicine.

[34]  A. Heisel,et al.  Sleep-related breathing disorders are associated with ventricular arrhythmias in patients with an implantable cardioverter-defibrillator. , 2002, Chest.

[35]  E. Berman,et al.  Right ventricular hypertrophy detected by echocardiography in patients with newly diagnosed obstructive sleep apnea. , 1991, Chest.

[36]  C. Bassetti,et al.  In vivo Platelet Activation Is Increased during Sleep in Patients with Obstructive Sleep Apnea Syndrome , 2002, Respiration.

[37]  Jagmeet P. Singh,et al.  Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. , 1998, Hypertension.

[38]  T. Rabben,et al.  Sleep-disordered breathing and coronary artery disease: long-term prognosis. , 2001, American journal of respiratory and critical care medicine.

[39]  J. Hedner,et al.  Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. , 1996, Journal of hypertension.

[40]  K. Lam,et al.  Serum leptin and vascular risk factors in obstructive sleep apnea. , 2000, Chest.

[41]  K. Franklin,et al.  Impairment of cerebral perfusion during obstructive sleep apneas. , 1994, American journal of respiratory and critical care medicine.

[42]  C Guilleminault,et al.  Cardiac arrhythmia and conduction disturbances during sleep in 400 patients with sleep apnea syndrome. , 1983, The American journal of cardiology.

[43]  J. Hedner,et al.  Impairment of vascular endothelial function and left ventricular filling : association with the severity of apnea-induced hypoxemia during sleep. , 2001, Chest.

[44]  T. D. Bradley,et al.  Overnight Shift From Obstructive to Central Apneas in Patients With Heart Failure: Role of Pco2 and Circulatory Delay , 2001, Circulation.

[45]  B. Sanner,et al.  Right ventricular dysfunction in patients with obstructive sleep apnoea syndrome. , 1997, The European respiratory journal.

[46]  J. Dimsdale,et al.  Effect of continuous positive airway pressure on blood pressure : a placebo trial. , 2000, Hypertension.

[47]  K. Chin,et al.  Effects of NCPAP therapy on fibrinogen levels in obstructive sleep apnea syndrome. , 1996, American journal of respiratory and critical care medicine.

[48]  F. Abboud,et al.  Sympathetic neural mechanisms in obstructive sleep apnea. , 1995, The Journal of clinical investigation.

[49]  Fabio Placidi,et al.  Carotid Artery Wall Thickness in Patients With Obstructive Sleep Apnea Syndrome , 2002, Stroke.

[50]  N. Montano,et al.  Contribution of tonic chemoreflex activation to sympathetic activity and blood pressure in patients with obstructive sleep apnea. , 1998, Circulation.

[51]  B. Sanner,et al.  Pulmonary hypertension in patients with obstructive sleep apnea syndrome. , 1997, Archives of internal medicine.

[52]  Michael Miller,et al.  Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure. A preliminary investigation. , 1995, Chest.

[53]  M. Aldrich,et al.  Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. , 1999, Sleep.

[54]  G. Parati,et al.  Clinical relevance blood pressure variability. , 1998, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[55]  W. Seeger,et al.  Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea. Impact of continuous positive airway pressure therapy. , 2000, American journal of respiratory and critical care medicine.

[56]  Y. Ouchi,et al.  Increased levels of circulating ICAM-1, VCAM-1, and L-selectin in obstructive sleep apnea syndrome. , 1999, Journal of applied physiology.

[57]  V. Somers,et al.  Impairment of Endothelium-Dependent Vasodilation of Resistance Vessels in Patients With Obstructive Sleep Apnea , 2000, Circulation.

[58]  V. Mohsenin,et al.  Sleep apnea in patients with hemispheric stroke. , 1995, Archives of physical medicine and rehabilitation.

[59]  R. Ross,et al.  Atherosclerosis is an inflammatory disease. , 1998, American heart journal.

[60]  G. Plazzi,et al.  Undiagnosed sleep‐disordered breathing among male nondippers with essential hypertension , 1997, Journal of hypertension.

[61]  B. Wuyam,et al.  High prevalence and persistence of sleep apnoea in patients referred for acute left ventricular failure and medically treated over 2 months. , 1999, European heart journal.

[62]  S. Javaheri.  Effects of continuous positive airway pressure on sleep apnea and ventricular irritability in patients with heart failure. , 2000, Circulation.

[63]  J Sellgren,et al.  Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? , 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[64]  R Colombo,et al.  Prognostic value of nocturnal Cheyne-Stokes respiration in chronic heart failure. , 1999, Circulation.

[65]  T. Rabben,et al.  Sleep-disordered breathing and myocardial ischemia in patients with coronary artery disease. , 2000, Chest.

[66]  B. Sanner,et al.  Platelet function in patients with obstructive sleep apnoea syndrome. , 2000, The European respiratory journal.

[67]  K. Nakao,et al.  Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. , 1999, Circulation.

[68]  C W Whitney,et al.  Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. , 2001, American journal of respiratory and critical care medicine.

[69]  S. Saarelainen,et al.  Circulating endothelin-1 in obstructive sleep apnea. , 1997, Endothelium : journal of endothelial cell research.

[70]  P. Hanly,et al.  ST-segment depression during sleep in obstructive sleep apnea. , 1993, The American journal of cardiology.

[71]  J. Hedner,et al.  Respiratory disturbance index: an independent predictor of mortality in coronary artery disease. , 2000, American journal of respiratory and critical care medicine.

[72]  J. Peter,et al.  Relations among hypoxemia, sleep stage, and bradyarrhythmia during obstructive sleep apnea. , 2000, American heart journal.

[73]  J. Hedner,et al.  Effect of nasal continuous positive airway pressure during sleep on 24-hour blood pressure in obstructive sleep apnea. , 1993, Sleep.

[74]  M. Alchanatis,et al.  Daytime Pulmonary Hypertension in Patients with Obstructive Sleep Apnea , 2001, Respiration.

[75]  K. Strohl,et al.  Blood flow of the middle cerebral artery with sleep-disordered breathing: correlation with obstructive hypopneas. , 1998, Stroke.

[76]  O. Parra.  Sleep-disordered breathing and stroke: is there a rationale for treatment? , 2001, The European respiratory journal.

[77]  J. Harbison,et al.  Cardiac rhythm disturbances in the obstructive sleep apnea syndrome: effects of nasal continuous positive airway pressure therapy. , 2000, Chest.

[78]  A. Harf,et al.  Prevalence of sleep-disordered breathing in patients on a heart transplant waiting list. , 1994, Chest.

[79]  T. Rabben,et al.  Sleep-disordered breathing in men with coronary artery disease. , 1996, Chest.

[80]  K. Lam,et al.  Obstructive sleep apnea is independently associated with insulin resistance. , 2002, American journal of respiratory and critical care medicine.

[81]  V. Somers,et al.  Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. , 2000, American journal of physiology. Heart and circulatory physiology.

[82]  D. Hui,et al.  Severe obstructive sleep apnea is associated with left ventricular diastolic dysfunction. , 2002, Chest.

[83]  J. Hedner,et al.  Platelet function and fibrinolytic activity in hypertensive and normotensive sleep apnea patients. , 1995, Sleep.

[84]  J. Laaban,et al.  Pulmonary arterial hypertension in patients with sleep apnoea syndrome , 2000, Thorax.

[85]  C. Guilleminault,et al.  Long-term nasal continuous positive airway pressure administration can normalize hypertension in obstructive sleep apnea patients. , 1993, Sleep.

[86]  M. Bonsignore,et al.  Catecholamines and blood pressure in obstructive sleep apnea syndrome. , 1993, Chest.

[87]  J. Sanderson,et al.  Prevalence of sleep-disordered breathing in diastolic heart failure. , 1997, Chest.

[88]  R. Mcevoy,et al.  Continuous positive airway pressure treatment improves pulmonary hemodynamics in patients with obstructive sleep apnea. , 2002, American journal of respiratory and critical care medicine.

[89]  Robert Wolk,et al.  Sleep‐Disordered Breathing and Cardiovascular Disease , 2003, Circulation.

[90]  E. Atkinson,et al.  Nocturnal dyspnea and atrial fibrillation predict Cheyne-Stokes respirations in patients with congestive heart failure. , 1995, Archives of internal medicine.

[91]  E. Bixler,et al.  SLEEP APNOEA IN A HYPERTENSIVE POPULATION , 1984, The Lancet.

[92]  J. Peter,et al.  Reversal of sinus arrest and atrioventricular conduction block in patients with sleep apnea during nasal continuous positive airway pressure. , 1995, American journal of respiratory and critical care medicine.

[93]  P. Hanly,et al.  Impact of obstructive sleep apnea on left ventricular mass and diastolic function. , 2001, American journal of respiratory and critical care medicine.

[94]  F. Abboud,et al.  Parasympathetic hyperresponsiveness and bradyarrhythmias during apnoea in hypertension , 1992, Clinical Autonomic Research.

[95]  D. Hudgel,et al.  Bilateral leg edema, obesity, pulmonary hypertension, and obstructive sleep apnea. , 2000, Archives of internal medicine.

[96]  Jan Hedner,et al.  Increased incidence of cardiovascular disease in middle-aged men with obstructive sleep apnea: a 7-year follow-up. , 2002, American journal of respiratory and critical care medicine.

[97]  S. Javaheri,et al.  Sleep apnea in 81 ambulatory male patients with stable heart failure. Types and their prevalences, consequences, and presentations. , 1998, Circulation.

[98]  V. Somers,et al.  Recent weight gain in patients with newly diagnosed obstructive sleep apnea. , 1999, Journal of hypertension.

[99]  J. Hedner,et al.  An independent association between obstructive sleep apnoea and coronary artery disease. , 1999, The European respiratory journal.

[100]  J. Weil,et al.  Bradycardia during sleep apnea. Characteristics and mechanism. , 1982, The Journal of clinical investigation.

[101]  A. Thilmann,et al.  Sleep-disordered breathing among patients with first-ever stroke , 2000, Journal of Neurology.

[102]  R. Mcevoy,et al.  Daytime pulmonary hemodynamics in patients with obstructive sleep apnea without lung disease. , 1999, American journal of respiratory and critical care medicine.

[103]  Robert Wolk,et al.  Elevated C-Reactive Protein in Patients With Obstructive Sleep Apnea , 2002, Circulation.

[104]  H. Kimura,et al.  Manifestation of pulmonary hypertension during REM sleep in obstructive sleep apnea syndrome. , 1999, American journal of respiratory and critical care medicine.

[105]  T. Rabben,et al.  Sleep-disordered breathing: a novel predictor of atrial fibrillation after coronary artery bypass surgery. , 1996, Coronary artery disease.

[106]  B. Sanner,et al.  Sleep‐disordered breathing in patients referred for angina evaluation—association with left ventricular dysfunction , 2001, Clinical cardiology.

[107]  C. Sullivan,et al.  Pulmonary hypertension in obstructive sleep apnoea. , 1995, The European respiratory journal.

[108]  J S Floras,et al.  Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. , 1999, American journal of respiratory and critical care medicine.

[109]  C. Guilleminault,et al.  Sleep-induced apnea syndrome. Prevalence of cardiac arrhythmias and their reversal after tracheostomy. , 1977, The American journal of medicine.

[110]  E. Fletcher,et al.  Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. , 1987, Sleep.

[111]  V. Somers,et al.  Nocturnal continuous positive airway pressure decreases daytime sympathetic traffic in obstructive sleep apnea. , 1999, Circulation.

[112]  T. Hayakawa,et al.  Changes in cerebral oxygenation and hemodynamics during obstructive sleep apneas. , 1996, Chest.

[113]  D. Levy,et al.  Echocardiographic features of the right heart in sleep-disordered breathing: the Framingham Heart Study. , 2001, American journal of respiratory and critical care medicine.

[114]  M. Littner,et al.  The prevalence of calcified carotid artery atheromas in patients with obstructive sleep apnea syndrome. , 1998, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[115]  F. Abboud,et al.  Potentiation of Sympathetic Nerve Responses to Hypoxia in Borderline Hypertensive Subjects , 1988, Hypertension.

[116]  N. Montano,et al.  Altered cardiovascular variability in obstructive sleep apnea. , 1998, Circulation.

[117]  Crispin Jenkinson,et al.  Ambulatory blood pressure after therapeutic and subtherapeutic nasal continuous positive airway pressure for obstructive sleep apnoea: a randomised parallel trial , 2002, The Lancet.

[118]  J. Peter,et al.  Heart block in patients with obstructive sleep apnoea: pathogenetic factors and effects of treatment. , 1998, The European respiratory journal.

[119]  J. Peter,et al.  Electrophysiologic evaluation of sinus node function and atrioventricular conduction in patients with prolonged ventricular asystole during obstructive sleep apnea. , 1996, The American journal of cardiology.

[120]  M. Miller,et al.  Disordered breathing and hypoxia during sleep in coronary artery disease. , 1982, Chest.

[121]  V. Somers,et al.  Investigating the relationship between stroke and obstructive sleep apnea. , 1996, Stroke.

[122]  F. Abboud,et al.  Influence of ventilation and hypocapnia on sympathetic nerve responses to hypoxia in normal humans. , 1989, Journal of applied physiology.

[123]  T. Rabben,et al.  Sleep-disordered breathing in women: occurrence and association with coronary artery disease. , 1996, The American journal of medicine.

[124]  M. Daly,et al.  An analysis of the primary cardiovascular reflex effects of stimulation of the carotid body chemoreceptors in the dog , 1962, The Journal of physiology.

[125]  Fenton Jc,et al.  TREATMENT OF HEPATIC ENCEPHALOPATHY BY ALTERATION OF INTESTINAL FLORA WITH LACTOBACILLUS ACIDOPHILUS. , 1965 .

[126]  J. Sorkin,et al.  Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. , 2002, American journal of respiratory and critical care medicine.

[127]  N. Montano,et al.  Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. , 1999, Circulation.

[128]  V. Somers,et al.  Effects of obstructive sleep apnea on endothelin-1 and blood pressure. , 1999, Journal of hypertension.

[129]  A. Xie,et al.  Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure , 1991, The Lancet.

[130]  R. Schulz,et al.  Prevalence of obstructive sleep apnoea in patients with coronary artery disease , 1996 .

[131]  B Akhtar,et al.  Intracranial hemodynamics in sleep apnea. , 1992, Chest.